IL-21 NK細胞展現膠芽瘤抗腫瘤潛力

Medical Supporter — Information Notice

This article is a summary of international medical information and is not medical advice; it cannot replace the diagnosis or treatment plan of your attending physician. The medical technologies, drug information and clinical data presented here are compiled from public literature and official statements of major Japanese medical institutions; the applicability and outcome of any therapy vary with each patient and must be assessed individually by a qualified physician.

Any specific treatment plan must be assessed by a licensed physician in Japan

IL-21 NK細胞展現膠芽瘤抗腫瘤潛力

2025年6月19日
讀畢需時 1 分鐘

#膠芽瘤 #癌症免疫治療 #NK細胞 #IL21 #抗腫瘤研究

�【IL-21 NK細胞展現膠芽瘤抗腫瘤潛力】IL-21表現的NK細胞對神經膠質瘤幹細胞樣細胞（GSCs）展現持續的抗腫瘤活性，體內外實驗證實了這一效果，為膠芽瘤治療帶來新的突破。

� 關鍵數據：✔ IL-21 NK細胞在體外對GSCs的抑制效果明顯，持續時間超過預期。✔ 在動物實驗中，膠芽瘤的腫瘤體積顯著減少。✔ NK細胞治療過程中，對正常細胞影響有限，安全性高。

� 更多詳情：https://tinyurl.com/2xqwwt26 � **對膠芽瘤研究有興趣或有問題？歡迎留言討論！

#膠芽瘤 #NK細胞 #IL21 #抗腫瘤研究 #醫療新聞� 想了解膠芽瘤最新研究成果及抗腫瘤療法的突破進展嗎？快來加入我們，與專家及志同道合的朋友一起探討最前沿的醫療資訊！

➡️【醫療助手】LINE 生活圈 � https://lin.ee/r8k7sNQ

➡️【抗癌情報站-醫療助手】Line bot � https://reurl.cc/rrn9vy

找到胰臟癌高侵略性關鍵！新免疫增強劑助攻癌症免疫治療京都大啟動iPS細胞癌症治療！

Considering medical care in Japan? Need information and support?

We help you organize the information needed for medical travel to Japan, liaise with Japanese medical institutions, and arrange a second-opinion consultation.The first consultation is free; an advisor will help you clarify the next steps.

Consult on LINE Contact an advisor

Fukuoka HQ: +81-92-409-5655

Formerly officially certified, No. B-066

圖片 1